Regeneron beats quarterly estimates on eczema drug strength, shares rise

This is a summary. Read the complete story at Investing.com below.

Related Stories

stocksabout 7 hours ago

AI stock selloff drives investors to China, India, and overlooked Asian sectors

Investing.com

stocksabout 8 hours ago

How to invest in AI amid AI spending worries?

Investing.com

stocksabout 10 hours ago

Russia stocks lower at close of trade; MOEX Russia Index unchanged

Investing.com